Xoma reported $-2280000 in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbvie ABBV:US $ 6567M 197M
Agenus AGEN:US $ -50.6M 17M
Agios Pharmaceuticals AGIO:US $ -94.77M 3.81M
Ardelyx ARDX:US $ -28.07M 8.16M
Biomarin Pharmaceutical BMRN:US $ 26.19M 92.76M
Bluebird Bio BLUE:US $ -122.15M 10.09M
Celldex Therapeutics CLDX:US $ -23.05M 2.9M
Chimerix CMRX:US $ -24.77M 14.73M
Curis CRIS:US $ -16.11M 2.49M
Epizyme EPZM:US $ -55.47M 4.84M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
Life Technologies LIFE:US $ -12.15M 3.59M
Macrogenics MGNX:US $ -66.44M 8.42M
Novartis NVS:US $ 3912M 230M
Novartis NOVN:VX SF 3912M 230M
Pfizer PFE:US $ 11328M 4083M
Prothena PRTA:US $ -37.96M 4.86M
Regeneron Pharmaceuticals REGN:US $ 1119.1M 1986M
Teva Pharmaceutical Industries TEVA:US $ 766M 253M
Xoma XOMA:US $ -2.28M 32.22M
YTE INCY:US $ 172.84M 1.75M